ArticleInflammation2026
Lipopolysaccharide-Induced Nasal Inflammation Swiftly Spreads Into the Olfactory Bulb, Accelerating its Network Activity and Uncoupling it from Breathing.
Article in Inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nasal inflammation-induced olfactory dysfunction is caused by sensory processing alterations in and beyond the olfactory epithelium, likely through the spreading of peripheral inflammation into the olfactory bulb (OB), damaging its neuronal computations. Although the consequences of chronic nasal inflammation have extensively described in animal models, their presence upon acute inflammation has not been evaluated. Thus, we tested whether acute nasal inflammation induced by a single lipopolysaccharide (LPS) intranasal application swiftly spreads into the OB, focusing on its microglia, interleukin 1 beta (IL-1β) levels, neuronal network activity, and olfactory function. We found that a single intranasal LPS application leads to early microglial morphological changes at OB granule cell-layer, along with increased IL-1β staining, the following day. Intranasal LPS application decreases slow OB network activity and increases fast OB network activity, while uncoupling its slow activity from breathing. Moreover, acute LPS-induced nasal inflammation dampens odor-induced OB network activation, correlating with deficient olfactory detection and discrimination. We conclude that acute LPS-induced nasal inflammation quickly spreads into the OB, mildly activating its microglia and disrupting its network activity and odor response, which likely contribute to olfactory impairment. These acute central nervous system alterations, whose mechanism remain to be determined, should be considered when diagnosing and treating inflammation-induced olfactory dysfunctions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.